Pramosone E label

Pramosone E

Pramosone E Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

Pramosone E™ Cream 2.5% is a topical preparation containing hydrocortisone acetate 2.5% w/w and pramoxine hydrochloride 1 % w/w in a hydrolipid base containing cetostearyl alcohol, ceteth 20, mineral oil, white petrolatum, propylparaben, triethanolamine lauryl sulfate, citric acid, sodium citrate, and purified water.

Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below.

Hydrocortisone-Acetate-structure

hydrocortisone acetate
Pregn-4-ene-3, 20-dione, 21-(acetyloxy)-11, 17-dihydroxy-, (11-beta)-
C23H32O6; mol. wt. 404.50

Pramoxine-HCl-structure

pramoxine hydrochloride
4-(3-(p-butoxyphenoxy)propyl)morpholine hydrochloride
C17H27NO3.HCl; mol. wt.:329.87

Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Pramosone E Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Pramosone E Manufacturers

  • Sebela Pharmaceuticals Inc.
    Pramosone E | Sebela Pharmaceuticals Inc.
    No Recall

    Pramosone E | Sebela Pharmaceuticals Inc.

    Pramosone E | Sebela Pharmaceuticals Inc.

    Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

  • Ferndale Laboratories, Inc.
    Pramosone E | Ferndale Laboratories, Inc.
    No Recall

    Pramosone E | Ferndale Laboratories, Inc.

    Pramosone E | Ferndale Laboratories, Inc.

    Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Login To Your Free Account